- Home
- HMST vs SCPH Comparison
HMST vs SCPH Comparison
Compare HMST & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HMST
- SCPH
- Stock Information
- Founded
- HMST 1921
- SCPH 2013
- Country
- HMST United States
- SCPH United States
- Employees
- HMST N/A
- SCPH N/A
- Industry
- HMST Major Banks
- SCPH Biotechnology: Pharmaceutical Preparations
- Sector
- HMST Finance
- SCPH Health Care
- Exchange
- HMST Nasdaq
- SCPH Nasdaq
- Market Cap
- HMST 191.6M
- SCPH 179.6M
- IPO Year
- HMST 2012
- SCPH 2017
- Fundamental
- Price
- HMST $11.00
- SCPH $3.24
- Analyst Decision
- HMST Buy
- SCPH Strong Buy
- Analyst Count
- HMST 2
- SCPH 2
- Target Price
- HMST $14.75
- SCPH $15.00
- AVG Volume (30 Days)
- HMST 195.0K
- SCPH 412.0K
- Earning Date
- HMST 01-27-2025
- SCPH 03-12-2025
- Dividend Yield
- HMST N/A
- SCPH N/A
- EPS Growth
- HMST N/A
- SCPH N/A
- EPS
- HMST N/A
- SCPH N/A
- Revenue
- HMST $169,710,000.00
- SCPH $30,278,000.00
- Revenue This Year
- HMST N/A
- SCPH $172.64
- Revenue Next Year
- HMST $17.03
- SCPH $131.43
- P/E Ratio
- HMST N/A
- SCPH N/A
- Revenue Growth
- HMST N/A
- SCPH 303.87
- 52 Week Low
- HMST $8.09
- SCPH $3.08
- 52 Week High
- HMST $16.10
- SCPH $6.54
- Technical
- Relative Strength Index (RSI)
- HMST 52.45
- SCPH 40.08
- Support Level
- HMST $9.36
- SCPH $3.27
- Resistance Level
- HMST $11.99
- SCPH $3.59
- Average True Range (ATR)
- HMST 0.53
- SCPH 0.20
- MACD
- HMST 0.09
- SCPH -0.01
- Stochastic Oscillator
- HMST 62.36
- SCPH 15.00
About HMST HomeStreet Inc.
HomeStreet Inc is a commercial bank. It provides commercial loans and consumer loans including mortgage loans, deposit products, private banking, and cash management services. The company loan products include commercial business loans and agriculture loans, consumer loans, single family residential mortgages, loans secured by commercial real estate and construction loans for residential and commercial real estate projects.
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.